Agilon Health Ownership
AGL Stock | USD 1.89 0.11 6.18% |
Shares in Circulation | First Issued 2018-12-31 | Previous Quarter 411.3 M | Current Value 411.6 M | Avarage Shares Outstanding 394.3 M | Quarterly Volatility 21.2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Agilon |
Agilon Stock Ownership Analysis
About 98.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. agilon health has Price/Earnings To Growth (PEG) ratio of 0.19. The entity recorded a loss per share of 0.76. The firm last dividend was issued on the February 17, 2016. Agilon Health had 2:1 split on the December 4, 1995. agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas. Agilon Health operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 646 people. For more info on agilon health please contact Steven Sell at 562 256 3800 or go to https://www.agilonhealth.com.Besides selling stocks to institutional investors, Agilon Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Agilon Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Agilon Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Agilon Health Quarterly Liabilities And Stockholders Equity |
|
Only 1.79% of agilon health are currently held by insiders. Unlike Agilon Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Agilon Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Agilon Health's insider trades
Agilon Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Agilon Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading agilon health backward and forwards among themselves. Agilon Health's institutional investor refers to the entity that pools money to purchase Agilon Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Bank Of America Corp | 2024-06-30 | 4.8 M | Charles Schwab Investment Management Inc | 2024-09-30 | 3 M | Millennium Management Llc | 2024-06-30 | 2.8 M | Northern Trust Corp | 2024-09-30 | 2.6 M | Citadel Advisors Llc | 2024-09-30 | 2.1 M | Citigroup Inc | 2024-09-30 | 2 M | Deutsche Bank Ag | 2024-06-30 | 1.8 M | Tudor Investment Corp Et Al | 2024-09-30 | 1.5 M | Aqr Capital Management Llc | 2024-06-30 | 1.4 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 112.8 M | Clayton Dubilier & Rice Llc | 2024-09-30 | 100 M |
agilon health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agilon Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agilon Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Agilon Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Agilon Health Outstanding Bonds
Agilon Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. agilon health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Agilon bonds can be classified according to their maturity, which is the date when agilon health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
AGROSU 46 20 JAN 32 Corp BondUS00857LAA52 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
US008513AA19 Corp BondUS008513AA19 | View | |
ADC 26 15 JUN 33 Corp BondUS008513AC74 | View | |
ADC 2 15 JUN 28 Corp BondUS008513AB91 | View | |
ADC 48 01 OCT 32 Corp BondUS008513AD57 | View | |
MGM Resorts International Corp BondUS552953CD18 | View |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.76) | Revenue Per Share 13.717 | Quarterly Revenue Growth 0.276 | Return On Assets (0.1) |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.